Porphyria - NYSORA

Explore NYSORA knowledge base for free:

Porphyria

Learning objectives

  • Describe porphyria
  • Recognize the symptoms and signs of porphyria
  • Anesthetic management of a patient with porphyria

Definition and mechanisms

  • Porphyrias are a heterogeneous group of inherited genetic disorders of heme biosynthesis
  • The heme biosynthetic pathway is most active in the liver and bone marrow
  • Porphyrins are organic cyclical compounds found in heme, the iron-containing ring structure found in hemoglobin, myoglobin, and all of the cytochromes

Classification

  • Acute porphyrias: Potential to develop acute neurovisceral crises
    • Acute intermittent porphyria (AIP)
    • Variegate porphyria (VP)
    • Hereditary coproporphyria (HCP)
    • 5-aminolaevulinic acid (ALA) dehydrase deficiency
    • Triggers for an acute crisis
      • Fasting
      • Dehydration
      • Infection
      • Drugs
      • Endogenous hormones
      • Stress
      • Smoking
      • Alcohol
  • Non-acute: Do not deteriorate into acute crises, less relevant for anesthesiologists 
    • Porphyria cutanea tarda
    • Congenital erythropoietic porphyria
    • Erythropoietic protoporphyria

Signs and symptoms

Presentation of an acute crisis

  • Almost all patients have severe abdominal pain, usually associated with tachycardia
  • Symptoms and signs of acute crises vary greatly and can mimic other conditions
Symptoms and signsFeaturesMay be misdiagnosed as
Abdominal painRecurrent, severe, poorly localized
Associated nausea and vomiting
Absence of fever or leucocytosis
Another cause of acute abdomen
Endometriosis/pelvic inflammatory disease
Irritable bowel syndrome
Opiate addiction
Cardiovascular signsTachycardia
Tachyarrhythmia
Hypertension
WeaknessProximal > distal
Upper limbs > lower
Up to 20% develop respiratory failure
May progress to bulbar paresis in severe cases
Guillain-Barré syndrome
Poliomyelitis
Acute lead poisoning
Vasculitis
Psychiatric featuresMood disturbance
Confusion
Psychosis
Anxiety disorder
Somatization disorder
Acute psychosis
Acute confusional state
Pain and sensory disturbanceBack, thigh, or extremity pain
Sensory neuropathy over the trunk
Chronic fatigue syndrome
Fibromyalgia
Chronic pain syndromes
SeizuresCNS manifestation of porphyria
Secondary to hyponatremia
Epilepsy
Other autonomic featuresConstipation
Gastoparesis
Postural hypotension
Cutaneous lesionsOnly in VP and HCP
Vesicular rash
Photosensitivity
Porphyria cutanea tarda
Bullous skin disease
Hyponatremia and other electrolyte disturbanceLow serum sodium
Low serum magnesium
Other disorders of sodium and water balance

Risk factors

  • Women are 4 to 5 times more likely to develop crises in their early thirties

Pathophysiology

porphyria, pathophysiology, ALA dehydratase deficiency, acute intermittent porphyria, congenital erythropoietic porphyria, porphyria cutanea tarda, hereditary coproporphyria, variegate porphyria, erythropoietic protoporphyria, acute porphyrias, non-acute porphyrias, heme, ALA synthase

Treatment

Once an acute crisis has been diagnosed, management consists of the following:

  • Remove or treat potential triggering factors and avoid a catabolic state
  • Administration of i.v. heme arginate 3 mg/kg daily for 4 days
  • Supportive measures
    • May require large doses of morphine to control pain
    • Antiemetics prochlorperazine and ondansetron are safe
    • Control tachycardia and hypertension with β-blockers
    • Avoid seizures via correcting hyponatremia and treating with gabapentin, vigabatrin, or levetiracetam
    • Sedation with propofol and alfentanil is safe

Management

porphyria, preoperative, intraoperative, postoperative, management, urine, 5-aminolevulinic acid, porphobilinogen, midazolam, droperidol, morphine, propofol, vecuronium, desflurane, atropine, neostigmine, ibuprofen, bupivacaine, fluids, heme, sodium, magnesium

Commonly used drugs and their safety profile 

DrugSafeUnsafeUndetermined
I.v. anesthetic agentsPropofolThiopentone, ketamineEtomidate
Inhalational anesthetic agentsIsoflurane, desflurane, nitrous oxideSevoflurane
Local anestheticsBupivacaine, prilocaine, lidocaineLevobupivacaine, ropivacaine
Neuromuscular blocking agents and removalSuccinylcholine, all non-depolarizing muscle relaxants, neostigmine
AnalgesicsFentanyl, alfentanil, remifentanil, morphine, hydromorphone, meperidine, tramadol, ibuprofen, aspirinOxycodone, diclofenacPentazocine, mefenamic acid
Sedative premedicationLorazepam, phenothiazines (chlorpromazine), temazepam
AntibioticsGentamicin, co-amoxiclav, penicillins, vancomycin, tazocin, meropenemRifampicin, erythromycin
Cardiovascular drugsAdrenaline, noradrenaline, milrinone, atropine, glycopyrrolate, β-blockers, phenylephrine, magnesium, angiotensin 2 inhibitors, fibrinolytic drugsEphedrineVasopressin, metaraminol
MiscellaneousSyntocin, carboprost, tranexamic acid, aprotininDexamethasone, hydrocortisone

Keep in mind

  • Anesthesiologists should be aware of the perioperative factors that may trigger or worsen an acute crisis in porphyria

Suggested reading

  • Findley H, Philips A, Cole D, Nair A. Porphyrias: implications for anaesthesia, critical care, and pain medicine. Continuing Education in Anaesthesia Critical Care & Pain. 2012;12(3):128-133.

We would love to hear from you. If you should detect any errors, email us customerservice@nysora.com